International Clinical Trial: Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07457918) titled 'Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)' on Feb. 24.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Verrica Pharmaceuticals Inc.

Condition: Common Warts (Verruca Vulgaris) Common Warts Human Papilloma Virus (HPV) Warts

Intervention: Combination Product: Cantharidin

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: March 2026

Target Sample Size: 600

Countries of Recruitment: U...